Low-dose bevacizumab plus atezolizumab enhances transarterial chemoembolization in HCC via correcting vascular-immune niche dysfunction
- DOI
- 10.1016/j.jhep.2026.07.028
- Published
- 2026-07
- Container
- Journal of Hepatology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jhep.2026.07.028,
title = {Low-dose bevacizumab plus atezolizumab enhances transarterial chemoembolization in HCC via correcting vascular-immune niche dysfunction},
author = {Chenghao Zhao and Huzheng Yan and Zhixing Liang and Haoyuan Yu and Luwen Mu and Zhanwang Xiang and Kun Li and Yongwei Hu and Zhengqi Wu and Tao Pan and Mingming Liu and Yang Yang and Linsen Ye and Mingsheng Huang},
year = {2026},
journal = {Journal of Hepatology},
doi = {10.1016/j.jhep.2026.07.028},
url = {https://doi.org/10.1016/j.jhep.2026.07.028}
}RIS
TY - JOUR TI - Low-dose bevacizumab plus atezolizumab enhances transarterial chemoembolization in HCC via correcting vascular-immune niche dysfunction AU - Chenghao Zhao AU - Huzheng Yan AU - Zhixing Liang AU - Haoyuan Yu AU - Luwen Mu AU - Zhanwang Xiang AU - Kun Li AU - Yongwei Hu AU - Zhengqi Wu AU - Tao Pan AU - Mingming Liu AU - Yang Yang AU - Linsen Ye AU - Mingsheng Huang PY - 2026 JO - Journal of Hepatology DO - 10.1016/j.jhep.2026.07.028 UR - https://doi.org/10.1016/j.jhep.2026.07.028 ER -
APA
Zhao, C., Yan, H., Liang, Z., Yu, H., Mu, L., Xiang, Z., Li, K., Hu, Y., Wu, Z., Pan, T., Liu, M., Yang, Y., Ye, L., & Huang, M. (2026). Low-dose bevacizumab plus atezolizumab enhances transarterial chemoembolization in HCC via correcting vascular-immune niche dysfunction. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2026.07.028
Source records
- crossref · retrieved 2026-09-25T09:30:46.761Z